ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc.
ORIC
時価総額
$6.1億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2020年
12月31日
2021年
12月31日
2022年
12月31日
Net loss
-74
-79
-89
Depreciation
1
1
1
Stock-based compensation expense
5
13
14
Loss on fixed asset disposals
-
-0
-0
(Accretion of discount) amortization of premium on investments, net
-0
-1
1
Prepaid expenses and other assets
2
-1
-1
Accounts payable and accrued other liabilities
4
3
-1
Net cash used in operating activities
-45
-60
-75
Acquisitions of property and equipment
1
1
2
Purchases of investments
225
70
238
Sales and maturities of investments
10
229
131
Net cash used in investing activities
-216
158
-109
Proceeds from issuance of common stock
133
50
25
Issuance costs associated with financings
-
2
0
Proceeds from issuance of common stock under the Employee Stock Purchase Plan
-
-
1
Proceeds from stock option exercises
0
1
0
Net cash provided by financing activities
251
49
25
Net (decrease) increase in cash and cash equivalents
-11
148
-159